Affinity Asset Advisors, LLC Q3 2021 Filing
Filed November 12, 2021
Portfolio Value
$396.0B
Holdings
73
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (73 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 700,000 | $88.0B | 22.22% | Put |
| 2 | SPYSPDR S&P 500 ETF TR | 100,000 | $42.9B | 10.84% | Put |
| 3 | BBIOBRIDGEBIO PHARMA INC | 654,435 | $30.7B | 7.75% | |
| 4 | —VINCERX PHARMA INC | 1,005,000 | $16.3B | 4.10% | |
| 5 | MORFMORPHIC HLDG INC | 270,755 | $15.3B | 3.87% | |
| 6 | NARIUSDINARI MED INC | 135,000 | $10.9B | 2.77% | |
| 7 | KURAKURA ONCOLOGY INC | 530,000 | $9.9B | 2.51% | |
| 8 | SWTXSPRINGWORKS THERAPEUTICS INC | 126,013 | $8.0B | 2.02% | |
| 9 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 259,966 | $7.7B | 1.94% | |
| 10 | OCULOCULAR THERAPEUTIX INC | 750,000 | $7.5B | 1.89% | |
| 11 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 7,000,000 | $7.1B | 1.78% | |
| 12 | —ARYA SCIENCES ACQUISITN CORP | 702,500 | $6.9B | 1.75% | |
| 13 | ACRSACLARIS THERAPEUTICS INC | 350,000 | $6.3B | 1.59% | |
| 14 | XLRNACCELERON PHARMA INC | 35,350 | $6.1B | 1.54% | |
| 15 | —ARYA SCIENCES ACQU CORP IV | 600,000 | $6.0B | 1.52% | |
| 16 | NAUTNAUTILUS BIOTECHNOLOGY INC | 975,000 | $6.0B | 1.51% | |
| 17 | ASNDASCENDIS PHARMA A/S | 35,910 | $5.7B | 1.45% | |
| 18 | ZNTLZENTALIS PHARMACEUTICALS INC | 77,500 | $5.2B | 1.30% | |
| 19 | MRTXEURMIRATI THERAPEUTICS INC | 27,500 | $4.9B | 1.23% | |
| 20 | TVTXTRAVERE THERAPEUTICS INC | 200,000 | $4.8B | 1.22% | |
| 21 | SAVACASSAVA SCIENCES INC | 75,000 | $4.7B | 1.18% | Put |
| 22 | —CURIS INC | 575,000 | $4.5B | 1.14% | |
| 23 | CYTKCYTOKINETICS INC | 125,000 | $4.5B | 1.13% | |
| 24 | ESTAESTABLISHMENT LABS HLDGS INC | 60,000 | $4.3B | 1.08% | |
| 25 | EDITEDITAS MEDICINE INC | 100,000 | $4.1B | 1.04% | Put |
| 26 | IOVAIOVANCE BIOTHERAPEUTICS INC | 150,000 | $3.7B | 0.93% | |
| 27 | NSTGEURNANOSTRING TECHNOLOGIES INC | 75,000 | $3.6B | 0.91% | |
| 28 | TREURTRILLIUM THERAPEUTICS INC | 200,000 | $3.5B | 0.89% | |
| 29 | CNTACENTESSA PHARMACEUTICALS PLC | 203,183 | $3.4B | 0.86% | |
| 30 | BLUBELLUS HEALTH INC NEW | 532,030 | $3.3B | 0.83% | |
| 31 | RFLRAFAEL HLDGS INC | 101,200 | $3.1B | 0.79% | Put |
| 32 | PRCTPROCEPT BIOROBOTICS CORP | 78,534 | $3.0B | 0.76% | |
| 33 | —ENVIRONMENTAL IMPACT ACQU CO | 300,000 | $3.0B | 0.75% | |
| 34 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.0B | 0.75% | |
| 35 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $2.9B | 0.74% | |
| 36 | RCKTROCKET PHARMACEUTICALS INC | 80,228 | $2.4B | 0.61% | |
| 37 | TCE2CELLDEX THERAPEUTICS INC NEW | 40,154 | $2.2B | 0.55% | |
| 38 | —CYCLACEL PHARMACEUTICALS INC | 400,000 | $2.1B | 0.53% | |
| 39 | GOSS 5 06/01/27GOSSAMER BIO INC | 2,000,000 | $2.1B | 0.53% | |
| 40 | NTLAINTELLIA THERAPEUTICS INC | 15,000 | $2.0B | 0.51% | |
| 41 | —HARPOON THERAPEUTICS INC | 250,000 | $2.0B | 0.50% | |
| 42 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 75,000 | $1.9B | 0.48% | |
| 43 | UTHUNITED THERAPEUTICS CORP DEL | 10,000 | $1.8B | 0.47% | |
| 44 | AFIBACUTUS MED INC | 200,000 | $1.8B | 0.45% | |
| 45 | ALDXALDEYRA THERAPEUTICS INC | 197,759 | $1.7B | 0.44% | |
| 46 | SEERSEER INC | 50,000 | $1.7B | 0.44% | Call |
| 47 | HZNPHORIZON THERAPEUTICS PUB L | 15,000 | $1.6B | 0.41% | |
| 48 | MREOMEREO BIOPHARMA GROUP PLC | 650,000 | $1.6B | 0.40% | |
| 49 | BFLYBUTTERFLY NETWORK INC | 150,000 | $1.6B | 0.40% | |
| 50 | —LIFESCI ACQUISITION II CORP | 150,000 | $1.5B | 0.37% | |
| 51 | SDGRSCHRODINGER INC | 25,000 | $1.4B | 0.35% | |
| 52 | PCVXVAXCYTE INC | 50,000 | $1.3B | 0.32% | |
| 53 | —ZYMEWORKS INC | 38,814 | $1.1B | 0.28% | |
| 54 | BLIUSDBERKELEY LTS INC | 55,000 | $1.1B | 0.27% | |
| 55 | AM6AMICUS THERAPEUTICS INC | 111,400 | $1.1B | 0.27% | |
| 56 | GLPGGALAPAGOS NV | 20,000 | $1.1B | 0.27% | |
| 57 | —BIOHAVEN PHARMACTL HLDG CO L | 7,500 | $1.0B | 0.26% | |
| 58 | —RENOVACOR INC | 115,000 | $1.0B | 0.26% | |
| 59 | 290ACHINOOK THERAPEUTICS INC | 74,341 | $949.0M | 0.24% | |
| 60 | LUNGPULMONX CORP | 25,000 | $900.0M | 0.23% | |
| 61 | IMTXIMMATICS N.V | 190,000 | $800.0M | 0.20% | |
| 62 | 698ACHILLES THERAPEUTICS PLC | 100,000 | $779.0M | 0.20% | |
| 63 | IPHAINNATE PHARMA S A | 125,000 | $771.0M | 0.19% | |
| 64 | XENEXENON PHARMACEUTICALS INC | 50,000 | $764.0M | 0.19% | |
| 65 | TNGXTANGO THERAPEUTICS INC | 50,000 | $647.0M | 0.16% | |
| 66 | CTMXCYTOMX THERAPEUTICS INC | 125,000 | $636.0M | 0.16% | |
| 67 | —THE BEAUTY HEALTH COMPANY | 34,400 | $498.0M | 0.13% | |
| 68 | KROSKEROS THERAPEUTICS INC | 12,500 | $495.0M | 0.13% | |
| 69 | —ASLAN PHARMACEUTICALS LTD | 250,000 | $445.0M | 0.11% | |
| 70 | IMVTIMMUNOVANT INC | 30,000 | $261.0M | 0.07% | Call |
| 71 | CRVSCORVUS PHARMACEUTICALS INC | 50,000 | $242.0M | 0.06% | |
| 72 | —RENOVACOR INC | 75,000 | $60.0M | 0.02% | |
| 73 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $24.0M | 0.01% |